Theravance Biopharma logo
Theravance Biopharma TBPH
$ 8.14 -0.86%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Theravance Biopharma Income Statement 2011-2024 | TBPH

Annual Income Statement Theravance Biopharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

519 M 754 M 633 M 1.16 B 1.56 B 1.36 B 1.41 B 1.26 B 561 M 516 M - - -

Shares

55.3 M 73.6 M 69.5 M 62.3 M 55.6 M 54 M 52.4 M 44.7 M 34.2 M 31.8 M - - -

Historical Prices

9.39 10.2 9.11 18.6 27.9 26.1 26.4 30 16.4 16.2 - - -

Net Income

-8.51 M -10.4 M -32 M -278 M -236 M -216 M -285 M -191 M -182 M -237 M -156 M -9.58 M -

Revenue

17.6 M 14.6 M 14.9 M 71.9 M 73.4 M 60.4 M 15.4 M 48.6 M 42.1 M 11.7 M 226 K 130 M -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - 73.4 M 59.7 M 9.36 M 45.8 M 37.5 M 7.63 M 226 K 130 M -

Operating Income

-6.24 M -17.4 M -56.2 M -298 M -252 M -239 M -260 M -180 M -182 M -233 M -156 M -9.58 M -

Interest Expense

2.35 M 6.37 M 8.55 M 8.55 M 31.9 M 10.5 M 8.55 M 1.4 M - - - - -

EBITDA

-4.34 M -14.8 M -52.7 M -294 M -245 M -236 M -264 M -177 M -179 M -229 M -154 M -6.32 M -

Operating Expenses

23.8 M 32.1 M 71.1 M 369 M 325 M 298 M 269 M 226 M 219 M 240 M 157 M 140 M -

General and Administrative Expenses

70.1 M 67.1 M 99.3 M 109 M 106 M 97.1 M 95.6 M 84.5 M 90.2 M 71.6 M - - -

All numbers in USD currency

Quarterly Income Statement Theravance Biopharma

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

48.7 M 48.3 M 48.1 M 52.4 M 56.7 M 62.9 M 65.2 M 75.5 M 76.3 M 75.2 M 74.4 M 73.6 M 65.7 M 64.5 M 64.3 M 63.3 M 63.3 M 60.1 M 57 M 56.7 M 56.4 M 55.8 M 55.7 M 55.2 M 55 M 53.3 M 54.4 M 52.6 M 52.3 M 51.6 M 52.8 M 46.5 M 44.4 M 38.3 M 38 M 33.7 M 33.5 M 32.8 M 32.2 M 31.8 M 31.8 M 31.7 M - 31.7 M 31.8 M - - - - - - - - -

Net Income

-16.5 M -11.7 M - -8.95 M -15.6 M -22.1 M - 917 M -8.19 M -25.9 M -32 M -35.3 M -52.4 M -79.7 M -58.4 M -73.6 M -62.9 M -83.1 M -65.6 M -58.4 M -39.8 M -72.6 M -50.2 M -59.4 M -40.8 M -65.1 M -86.9 M -66.9 M -66.3 M -65.3 M -67.3 M -34 M -47.2 M -42.2 M -44.8 M -47.3 M -47.6 M -42.5 M -64.3 M -54.5 M -58.2 M -60 M -44.1 M -41.1 M -39 M -32.2 M - - - - - - - -

Revenue

14.3 M 14.5 M - 15.7 M 13.7 M 10.4 M - 12.5 M 11 M 13.2 M 14.9 M 13.2 M 12.9 M 14.3 M 18.7 M 18.3 M 15 M 19.9 M 29.5 M 12.4 M 26.2 M 5.34 M 15.7 M 12.8 M 23.5 M 8.32 M 4.52 M 4.28 M 3.51 M 3.09 M 5.69 M 19.1 M 5.47 M 18.4 M 3.89 M 10.7 M 7.13 M 20.4 M 1.43 M 6.34 M 2.97 M 945 K 175 K 24 K 5 K 22 K - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-15.7 M -11.2 M - -8.76 M -16.1 M -24.9 M - -14.2 M -23.1 M -37.2 M -56.2 M -53.6 M -64.1 M -83.9 M -76.5 M -76.6 M -72.2 M -72.5 M -70.6 M -65.2 M -42.5 M -73.7 M -62.6 M -62.4 M -48.7 M -65 M -79.2 M -57 M -65.1 M -58.8 M -57.8 M -33.5 M -47.5 M -41.6 M -55.8 M -43.1 M -45.3 M -37.7 M -65.8 M -50.1 M -56.7 M -60 M -44.1 M -41.1 M -39 M -32.2 M - - - - - - - -

Interest Expense

1.13 M 629 K - 609 K 2.5 M 550 K - 1.54 M 2.14 M 2.14 M - 2.14 M 11.6 M 11.9 M - 11.6 M 11.4 M 9.94 M - 8.07 M 7.9 M 7.86 M - 2.14 M 2.14 M 2.14 M - 2.14 M 2.14 M 2.14 M - - - - - 104 K 204 K 211 K - 668 K 214 K - - - - - - - - - - - - -

EBITDA

- - - - - - - -14.2 M -23.1 M -37.2 M -56.2 M -53.6 M -64.1 M -83.9 M -76.5 M -76.6 M -72.2 M -72.5 M -70.6 M -65.2 M -42.5 M -72.4 M -62.6 M -62.4 M -48.7 M -64 M -79.2 M -54 M -63.1 M -57.7 M -57.8 M -31.6 M -46.3 M -40.9 M -55.8 M -40.8 M -43.7 M -36.9 M -65.8 M -47.6 M -55.3 M -59.3 M -44.1 M -39.1 M -37.6 M -31.5 M - - - - - - - -

Operating Expenses

30 M 25.7 M - 24.5 M 29.9 M 35.3 M - 26.7 M 34.2 M 50.4 M 71.1 M 66.8 M 77 M 98.1 M 95.2 M 94.9 M 87.2 M 92.3 M 100 M 77.6 M 68.6 M 79 M 78.4 M 75.3 M 72.2 M 73.3 M 83.7 M 61.3 M 68.6 M 61.9 M 63.5 M 52.6 M 53 M 60.1 M 59.7 M 53.8 M 52.4 M 58.1 M 67.2 M 56.4 M 59.7 M 61 M 44.3 M 41.1 M 39 M 32.2 M - - - - - - - -

General and Administrative Expenses

17.1 M 16.7 M - 16.1 M 19.3 M 19.2 M - 16.3 M 16.2 M 17.8 M - 21.3 M 25.9 M 30.6 M - 27.5 M 24.8 M 26.3 M - 25.6 M 22.2 M 25.2 M - 21.9 M 25 M 24.7 M - 20.9 M 24.3 M 20.8 M - 20.3 M 20.3 M 23.6 M - 22.8 M 21.5 M 21.7 M - 17.7 M 13.1 M 19.1 M - 8.8 M 8.56 M 6.79 M - - - - - - - -

All numbers in USD currency